31 days of COVID-19-cardiac events during restriction of public life-a comparative study

Manuel Rattka1, Michael Baumhardt1, Jens Dreyhaupt2

  • 1Clinic for Internal Medicine II, University Hospital Ulm-Medical Center, Albert Einstein Allee 23, 89081, Ulm, Germany.

Insights

The COVID-19 pandemic and lockdowns significantly reduced hospital admissions for acute cardiac events. Strategies are needed to ensure timely medical care during pandemics.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • The SARS-CoV-2 pandemic prompted widespread public health interventions, including lockdowns.
  • The impact of these measures on hospital admissions for acute cardiac events remains under-evaluated.

Purpose of the Study:

  • To assess the effect of the SARS-CoV-2 pandemic and social restrictions on hospital admissions for acute cardiac events.
  • To compare admission rates during the lockdown period with previous years.

Main Methods:

  • Retrospective analysis of patients admitted with acute cardiac events at a tertiary care center in Germany.
  • Comparison of admission data from March 21st to April 20th, 2020, with the same period in 2017-2019.
  • Calculation of incidence rate ratios (IRR) for overall admissions and specific cardiac events.

Main Results:

  • Overall cardiac event admissions decreased by 22% during the lockdown period (94 patients vs. an average of 120 annually).
  • Admissions for Non-ST-Elevation Myocardial Infarction (NSTEMI) significantly decreased (IRR 0.46).
  • ST-Elevation Myocardial Infarction (STEMI) and out-of-hospital cardiac arrest admissions showed no significant change, but STEMI patients had higher troponin levels upon admission.

Conclusions:

  • The SARS-CoV-2 pandemic and associated social restrictions led to fewer hospital admissions for acute cardiac events.
  • Public health strategies must be developed to ensure patients seek and receive timely medical care during pandemic situations.
Abstract

Related Concept Videos

Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
341
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
523
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
140
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
235
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
328
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
277